Wockhardt Shares Drop More Than 5% Amid U.S. Tariff Announcement

Mumbai, September 26, 2025 – Wockhardt Ltd (NSE: WOCKPHARMA) shares fell 5.93% during afternoon trade on Friday, September 26, 2025. This drop follows U.S. President Donald Trump’s announcement of a 100% import tariff on branded and patented pharmaceutical products, effective October 1, 2025.

Stock Performance

As of 12:15 pm IST the Wockhardt stock was trading at ₹1,388.50 down ₹87.60. The stock opened at ₹1,446.00 and hitting a low of ₹1,375.10, which added to the overall sell-off in the pharma space.

Sector-Wide Impact

The tariff news has generated across-the-board fear among Indian pharma companies, many of which have significant dependence on exports to the American market. Even Sun Pharma, Natco Pharma, and Aurobindo Pharma witnessed sharp drops, some of them down more than 5%. The Nifty Pharma index fell 2.4%, a reflection of the U.S. trade policy vulnerability of the sector.

Policy Implications

The new tariffs aim at patented and branded medicines, leaving behind generic medicines and firms with established or intended U.S. manufacturing facilities. Nevertheless, investors have been unnerved by the uncertainty relating to the scope of the exemptions. Analysts warn that if the tariffs climb as signaled before—up to 250%—then the entire sector may be severely adversely affected.

Wockhardt’s Strategic Response

Wockhardt, in April 2025, said it would pull out of the U.S. generics business, which commands around a 5% market share in America. Chairperson Habil Khorakiwala said it would be “very, very difficult” to manufacture all products in America and would also require several years to do so. The strategic move can reduce the blow of the new tariffs on the business.

Investor Outlook

The healthcare industry’s swift reaction to the tariff announcement testifies to the market’s sensitivity to U.S. trade policy. Investors should watch events closely, especially in terms of implementation of tariffs and any possible exemptions or modifications. The developing scenario can result in higher volatility in the sector.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations